Accuray Inc

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $166.40M
  • PE 247
  • Debt $182.57M
  • Cash $80.24M
  • EV $268.73M
  • FCF $19.03M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$673.00K
EBIT$10.42M
ROE1%
ROA2%
FCF$19.03M
Equity$49.58M
Growth Stability1
PE247.25
PEG-40.46
PB3.36
P/FCF8.74
P/S0.36
Price/Cash0.48
Debt/Equity3.68
Debt/FCF9.59
Net Margins-1%
Gross Margins31%
Op. Margins2%
Earnings CAGR-1%
Sales Growth YoY12%
Sales Growth QoQ-3%
Sales CAGR2%
FCF CAGR-0%
Equity CAGR-1%
Earnings Stability0.01
Earnings Growth YoY-80%
Earnings Growth QoQ-151%
Earnings CAGR 5Y-6%
Sales CAGR 5Y4%
FCF CAGR 5Y-7%
Equity CAGR 5Y-9%
Earnings CAGR 3Y3%
Sales CAGR 3Y3%
FCF CAGR 3Y20%
Equity CAGR 3Y-5%
Market Cap$166.40M
Revenue$465.25M
Assets$484.29M
Total Debt$182.57M
Cash$80.24M
Shares Outstanding101.46M
EV268.73M
Earnings Score6%
Moat Score23%
Safety Score67%
Final Score32%
Working Capital130.03M
Current Ratio1.64
Gross Profit$146.44M
Shares Growth 3y4%
Equity Growth QoQ4%
Equity Growth YoY21%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide.

SEC Filings

Direct access to Accuray Inc (ARAY) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2025
    • 10-Q Mar 31
  • 2024
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Accuray Inc compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Accuray Inc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR -1%
Stability 1%
loading chart...

Accuray Inc Discounted Cash Flow

Fully customizable DCF calculator online for Accuray Inc.

= $184M
012345678910TV
fcf$19M$19M$19M$19M$19M$19M$19M$18M$18M$18M$18M$182M
DCF$17M$16M$14M$13M$12M$10M$9.5M$8.6M$7.7M$7M$70M
Value$184M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024TTM
Net Margins-11%-6%-8%-6%-4%1%-2%-1%-2%-3%-1%
ROA--1%-2%-1%0%3%5%2%0%0%2%
ROE--43%-64%-49%-33%6%-9%-10%-17%-34%1%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024TTM
Debt over FCF-10.2-51.6712.33-5.19-40.25.71-27.0463.49-11.729.59
Debt over Equity2.844.356.013.063.543.1833.623.464.033.68
Growth Stability----------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024CAGR 5Y
Revenue YoY growth-5%-4%6%3%-9%3%8%4%-0%4%
Earnings YoY growth--37%16%-19%-31%-123%-265%-15%74%68%-6%
Equity YoY growth--21%-22%5%3%28%8%-23%1%-16%-9%
FCF YoY growth--202%-121%-323%-382%-85%-820%-120%-141%-630%-7%